- Home
- BLCO vs HR Comparison
BLCO vs HR Comparison
Compare BLCO & HR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLCO
- HR
- Stock Information
- Founded
- BLCO 1853
- HR 1992
- Country
- BLCO Canada
- HR United States
- Employees
- BLCO N/A
- HR N/A
- Industry
- BLCO Ophthalmic Goods
- HR Real Estate Investment Trusts
- Sector
- BLCO Health Care
- HR Real Estate
- Exchange
- BLCO Nasdaq
- HR Nasdaq
- Market Cap
- BLCO 4.9B
- HR 5.3B
- IPO Year
- BLCO 2022
- HR 1993
- Fundamental
- Price
- BLCO $13.99
- HR $16.10
- Analyst Decision
- BLCO Hold
- HR Hold
- Analyst Count
- BLCO 13
- HR 5
- Target Price
- BLCO $15.83
- HR $16.40
- AVG Volume (30 Days)
- BLCO 785.5K
- HR 4.0M
- Earning Date
- BLCO 07-30-2025
- HR 08-01-2025
- Dividend Yield
- BLCO N/A
- HR 7.70%
- EPS Growth
- BLCO N/A
- HR N/A
- EPS
- BLCO N/A
- HR N/A
- Revenue
- BLCO $4,829,000,000.00
- HR $1,240,776,000.00
- Revenue This Year
- BLCO $6.97
- HR N/A
- Revenue Next Year
- BLCO $5.48
- HR $2.47
- P/E Ratio
- BLCO N/A
- HR N/A
- Revenue Growth
- BLCO 11.94
- HR N/A
- 52 Week Low
- BLCO $10.45
- HR $14.09
- 52 Week High
- BLCO $21.69
- HR $18.90
- Technical
- Relative Strength Index (RSI)
- BLCO 69.08
- HR 68.04
- Support Level
- BLCO $12.02
- HR $15.69
- Resistance Level
- BLCO $14.35
- HR $16.31
- Average True Range (ATR)
- BLCO 0.46
- HR 0.35
- MACD
- BLCO 0.15
- HR 0.05
- Stochastic Oscillator
- BLCO 85.82
- HR 81.14
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
About HR Healthcare Realty Trust Incorporated
Healthcare Realty Trust Inc is a healthcare facility real estate investment trust. The company focuses on owning, leasing, and managing outpatient facilities and other healthcare properties. The company works to invest in outpatient facilities that are integral to a hospital's operations. It generates all of its revenue in the United States.